Erratum

Article Outline

• Copyright

In the June 2010 issue (4/3) of Journal of Clinical Lipidology, in the section titled “Scientific Poster Abstracts Selected for the National Lipid Association 2010 Annual Scientific Sessions” (2010;4:198-231), changes were made post-submission as noted below.

Abstract 104, entitled “Response by Sex to Statin and Ezetimibe Versus Statin Monotherapy: Pooled Analysis from 22,913 Hyperlipidemic Patients” (2010;4:200), inadvertently had a co-author omitted from the original submission. Please recognize Beth L. Abramson as one of the contributing authors.

In abstract 105, entitled “Achievement of Specified Lipid and High-Sensitivity C-Reactive Protein Levels wth Statin-Ezetimibe Versus Statin in Male and Female Patients Using Combined Data from 22,913 Patients” (2010;4;200), the authors should appear as: Jennifer Robinson, MD, MPH, Beth L. Abramson, Mary E. Hanson, Jianxin Lin, Arvind Shah, Andrew M. Tershakovec.

Abstract 119, entitled “Ezetimibe/Simvastatin 10/20 mg Versus Rosuvastatin 10 mg in High Risk Hypercholesterolemic Patients Stratified by Previous Statin Treatment Potency” (2010;4:207), inadvertently supplied an incorrect author on the original submission. The correct authors of this abstract should be, Michael Farnier, MD, Margus Viigimaa, Helena Vaverkova, Maurizio Averna, Luc Missault, Qian Dong, Arvind Shah, Mary E. Hanson, Philippe Brudi.